Biotechnology (108) | Change of Control Agreements (108)
Browse by Company
-
Adverum Biotechnologies, Inc. (7)
-
Aldeyra Therapeutics, Inc. (1)
-
Alector, Inc. (1)
-
ALNYLAM PHARMACEUTICALS, INC. (1)
-
AMARIN CORP PLC (1)
-
Applied Molecular Transport Inc. (1)
-
Arcutis Biotherapeutics, Inc. (10)
-
ARDELYX, INC. (2)
-
AVEO PHARMACEUTICALS INC (2)
-
Biomea Fusion, Inc. (1)
-
CareDx, Inc. (1)
-
Constellation Alpha Capital Corp. (2)
-
Cortexyme, Inc. (7)
-
Corvus Pharmaceuticals, Inc. (1)
-
CytomX Therapeutics, Inc. (8)
-
Denali Therapeutics Inc. (1)
-
Epizyme, Inc. (1)
-
FIBROGEN INC (1)
-
Global Blood Therapeutics, Inc. (4)
-
IDERA PHARMACEUTICALS, INC. (2)
-
IGM Biosciences, Inc. (1)
-
IMMUNOGEN INC (2)
-
Invitae Corp (2)
-
MeiraGTx Holdings plc (1)
-
Myriad Genetics, Inc. (1)
-
NOVAVAX INC (1)
-
OncoCyte Corp (3)
-
ONCOSEC MEDICAL Inc (1)
-
Organogenesis Holdings Inc. (3)
-
ORGANOVO HOLDINGS, INC. (1)
-
Oric Pharmaceuticals, Inc. (1)
-
Oyster Point Pharma, Inc. (1)
-
Principia Biopharma Inc. (1)
-
ROCKET PHARMACEUTICALS, INC. (1)
-
Sarepta Therapeutics, Inc. (1)
-
Sorrento Therapeutics, Inc. (1)
-
Stoke Therapeutics, Inc. (4)
-
SUTRO BIOPHARMA, INC. (2)
-
T2 Biosystems, Inc. (4)
-
Tenaya Therapeutics, Inc. (1)
-
Vaxcyte, Inc. (1)
-
VERACYTE, INC. (9)
-
Vertex Pharmaceuticals Inc (3)
-
Vir Biotechnology, Inc. (1)
-
VITAL THERAPIES INC (1)
-
ZAFGEN, INC. (5)
Recent Contracts
-
Change in Control and Executive Severance Plan Agreement, dated October 4 2021, between Oncocyte Corporation and Gisela Paulsen
(OncoCyte Corp, Filed With SEC on October 7, 2021)
-
Form of Change in Control and Severance Agreement, between Invitae Corporation and certain officers
(Invitae Corp, Filed With SEC on August 9, 2021)
-
Change in Control and Severance Agreement, between Invitae Corporation and Sean George
(Invitae Corp, Filed With SEC on August 9, 2021)
-
Change in Control and Severance Agreement, by and between Cortexyme Inc. and Casey C. Lynch, dated as of May 19, 2021
(Cortexyme, Inc., Filed With SEC on August 6, 2021)
-
Change in Control and Severance Agreement, by and between Cortexyme Inc. and Caryn McDowell, dated as of May 18, 2021
(Cortexyme, Inc., Filed With SEC on August 6, 2021)
-
Change in Control and Severance Agreement, by and between Cortexyme Inc. and Christopher Lowe, dated as of May 18, 2021
(Cortexyme, Inc., Filed With SEC on August 6, 2021)
-
Change in Control and Severance Agreement, by and between Cortexyme Inc. and Leslie Holsinger, dated as of May 18, 2021
(Cortexyme, Inc., Filed With SEC on August 6, 2021)
-
Change in Control and Severance Agreement, by and between Cortexyme Inc. and Michael Detke, dated as of May 21, 2021
(Cortexyme, Inc., Filed With SEC on August 6, 2021)
-
Change in Control and Severance Agreement, by and between Cortexyme Inc. and Stephen S. Dominy, M.D., dated as of May 19, 2021
(Cortexyme, Inc., Filed With SEC on August 6, 2021)
-
Novavax, Inc. Amended and Restated Change in Control Severance Benefit Plan
(NOVAVAX INC, Filed With SEC on August 5, 2021)
